This NDC is on FDA's drug shortage list (posted Jul 14, 2023)
Product Information
LISDEXAMFETAMINE 60 MG TB CHEW is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $3.6460 per EA under NDC 72205013791. Its NADAC has been published 100 times since Nov 6, 2024.
FDA first approved this application on Feb 2, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205013791
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LISDEXAMFETAMINE DIMESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA218306FDA Approved
2/2/2024
TE Code
AB
On Market Since
2/2/2024
Pharmacological Classes
Price Statistics
The NADAC for LISDEXAMFETAMINE 60 MG TB CHEW has been published 100 times since Nov 6, 2024, and over the history we have for it it has declined 57.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.6460 per EA |
|---|---|
| All-time high | $8.6521 (May 14, 2025) |
| All-time low | $3.5101 (Aug 19, 2026) |
| 52-week high | $5.7542 |
| 52-week low | $3.5101 |
| Median price | $5.6352 |
| Average price | $6.2028 |
| Largest weekly change | -12.5% (Aug 20, 2025) |
| Weeks tracked | 100 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novadoz Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lisdexamfetamine dimesylate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LISDEXAMFETAMINE 60 MG TB CHEW?
The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 60 MG TB CHEW, manufactured by Novadoz Pharmaceuticals LLC, is $3.6460 per EA (NDC 72205013791), effective Sep 30, 2026.
How has the price of LISDEXAMFETAMINE 60 MG TB CHEW changed over time?
Over the history we have for it, the NADAC for LISDEXAMFETAMINE 60 MG TB CHEW has declined 57.7%. It has been tracked across 100 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 60 MG TB CHEW?
Since Nov 6, 2024, the NADAC for LISDEXAMFETAMINE 60 MG TB CHEW has ranged from a low of $3.5101 (Aug 19, 2026) to a high of $8.6521 (May 14, 2025), with a median of $5.6352 per EA.
Are there cheaper alternatives to LISDEXAMFETAMINE 60 MG TB CHEW?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LISDEXAMFETAMINE 60 MG TB CHEW in a comparable dosage form, but none are currently priced below it.
Who manufactures LISDEXAMFETAMINE 60 MG TB CHEW?
LISDEXAMFETAMINE 60 MG TB CHEW (NDC 72205013791) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.
Is LISDEXAMFETAMINE 60 MG TB CHEW in shortage?
Yes — NDC 72205013791 is currently listed in FDA's drug shortage database (posted Jul 14, 2023).